U.S. Markets closed

BIOLASE, Inc. (BIOL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2800-0.0056 (-1.96%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2856
Open0.2900
Bid0.2810 x 800
Ask0.2851 x 800
Day's Range0.2800 - 0.2900
52 Week Range0.2100 - 1.0700
Volume1,105,841
Avg. Volume7,228,132
Market Cap25.813M
Beta (5Y Monthly)1.94
PE Ratio (TTM)N/A
EPS (TTM)-0.6650
Earnings DateAug 13, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 24, 2005
1y Target Est1.63
  • BIOLASE Hosts Nearly 400 Dental Professionals During Webinar On Landmark Study On Lasers And Managing Periodontitis
    PR Newswire

    BIOLASE Hosts Nearly 400 Dental Professionals During Webinar On Landmark Study On Lasers And Managing Periodontitis

    BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it hosted nearly 400 dental professionals last Thursday evening during a panel discussion on the NEW Journal of Periodontology landmark study from the McGuire Institute comparing periodontal flap surgery to BIOLASE's REPAIR Perio laser protocol in managing periodontitis.

  • BIOLASE To Present At H.C. Wainwright's 22nd Annual Global Investor Conference
    PR Newswire

    BIOLASE To Present At H.C. Wainwright's 22nd Annual Global Investor Conference

    BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements at the H.C. Wainwright 22nd Annual Global Investor Conference on Wednesday, September 16, 2020 at 11:00 am Pacific Time (2:00 pm ET).

  • BIOLASE to Highlight Progress and Recent Achievements at the Colliers & Co. Institutional Investor Conference
    PR Newswire

    BIOLASE to Highlight Progress and Recent Achievements at the Colliers & Co. Institutional Investor Conference

    BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements at the Colliers & Co. Institutional Investor Conference on Thursday, September 10, 2020. The conference will feature virtual one-on-one meetings with the BIOLASE' executives and institutional investors are invited to request meeting times at tkehrli@evcgroup.com or through their Colliers representative.